Publications by authors named "Bishwa Ganguly"
Mol Cancer Ther
September 2009
Article Synopsis
- Monoclonal antibody therapy, specifically elotuzumab targeting the CS1 protein, shows promise for treating multiple myeloma, a type of blood cancer, despite previous challenges due to a lack of suitable targets.
- Elotuzumab was found to effectively kill myeloma cells in bone marrow environments and its efficacy could be boosted when combined with bortezomib, a drug that inhibits proteasomes and is already used in myeloma treatment.
- The study suggests that a clinical trial should test the combination of elotuzumab and bortezomib to potentially improve treatment outcomes for patients with relapsed or refractory multiple myeloma.
